Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$119,854,034
-$16,332,112 QoQ
Shares Held
4,977,327
+2.6% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#91
of 2,826 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AVIVA PLC holds $4,883,087,810 across 10 Drug Manufacturers - General names. PFE ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
10,899,700 | $2,066,801,114 | |
| 2 | LLY |
ELI LILLY & Co
|
718,261 | $861,503,863 | |
| 3 | JNJ |
Johnson & Johnson
|
2,162,709 | $549,263,204 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,264,106 | $419,437,621 | |
| 5 | ABBV |
AbbVie Inc.
|
1,664,656 | $418,894,035 | |
| 6 | AMGN |
Amgen Inc
|
471,664 | $170,798,967 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,183,858 | $149,568,619 | |
| 8 | PFE |
Pfizer Inc
This page
|
4,977,327 | $119,854,034 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,854,034 | 4,977,327 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $136,186,146 | 4,849,934 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $117,310,523 | 4,711,266 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $113,660,674 | 4,460,780 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $102,769,309 | 4,239,658 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $100,362,820 | 3,960,648 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $90,569,201 | 3,413,841 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $99,732,246 | 3,446,173 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $94,175,587 | 3,365,818 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $75,243,237 | 2,711,468 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $84,826,452 | 2,946,386 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $92,400,408 | 2,785,662 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $106,223,115 | 2,895,941 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $94,921,444 | 2,326,506 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $116,055,166 | 2,264,933 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $86,028,615 | 1,965,919 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $99,404,029 | 1,895,938 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $73,387,805 | 1,417,574 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $51,483,037 | 871,855 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $44,749,582 | 1,040,446 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $72,951,594 | 1,862,911 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $72,087,012 | 1,989,705 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $73,391,593 | 1,993,795 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $71,474,867 | 1,947,546 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $66,157,007 | 2,023,148 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $68,748,429 | 2,106,266 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||